{"transactions":[{"id":758506,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T20:01:13.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":1573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting."}],"balance_after":7171,"source":{"system":"sec-edgar","filing":"0001643528-26-000003","document":"wk-form4_1780084869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388658/000164352826000003/wk-form4_1780084869.xml","form_type":"4"}},{"id":1130287,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-29T20:06:28.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":1358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting."}],"balance_after":5598,"source":{"system":"sec-edgar","filing":"0001388658-25-000138","document":"wk-form4_1748549182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865825000138/wk-form4_1748549182.xml","form_type":"4"}},{"id":1494861,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T22:48:43.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":1841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of IRTC Common Stock.   The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting."}],"balance_after":4240,"source":{"system":"sec-edgar","filing":"0001388658-24-000121","document":"wk-form4_1717454913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865824000121/wk-form4_1717454913.xml","form_type":"4"}},{"id":1866391,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T20:35:17.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":2399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest over a three-year period on June 1, 2024, and each one-year anniversary thereafter,  subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":2399,"source":{"system":"sec-edgar","filing":"0001388658-23-000085","document":"wk-form4_1685997286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000085/wk-form4_1685997286.xml","form_type":"4"}},{"id":393964,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2020-03-03T22:12:35.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":14318,"price":79.19,"value":1133842.42,"ownership":{"direct":true},"balance_after":114099,"source":{"system":"sec-edgar","filing":"0001179110-20-002892","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002892/edgar.xml","form_type":"4"}},{"id":394504,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2020-02-25T22:19:44.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":85562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 28,520 on February 21, 2021, 28,521 on February 21, 2022, and 28,521 on February 21, 2023."}],"balance_after":85562,"derivative":{"exercise_price":87.72,"exercise_date":"2021-02-21","expiration_date":"2030-02-20","underlying":"Common shares","underlying_shares":85562},"source":{"system":"sec-edgar","filing":"0001179110-20-002269","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002269/edgar.xml","form_type":"4"}},{"id":394503,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2020-02-25T22:19:44.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":14036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":128417,"source":{"system":"sec-edgar","filing":"0001179110-20-002269","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002269/edgar.xml","form_type":"4"}},{"id":396417,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":false,"shares":82321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":164642,"derivative":{"exercise_price":59.94,"exercise_date":"2019-02-16","expiration_date":"2028-02-15","underlying":"Common shares","underlying_shares":82321},"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396416,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":false,"shares":91121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":45561,"derivative":{"exercise_price":44.4,"exercise_date":"2019-02-17","expiration_date":"2027-02-16","underlying":"Common shares","underlying_shares":91121},"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396415,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":false,"shares":213470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":38.4,"exercise_date":"2019-02-19","expiration_date":"2026-02-18","underlying":"Common shares","underlying_shares":213470},"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396414,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":false,"shares":81709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":48.9,"exercise_date":"2018-06-01","expiration_date":"2025-05-31","underlying":"Common shares","underlying_shares":81709},"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396413,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":false,"shares":41229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":47,"exercise_date":"2018-02-20","expiration_date":"2025-02-19","underlying":"Common shares","underlying_shares":41229},"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396412,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"sale","acquired":false,"shares":509850,"price":89.7268,"value":45747208.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.57 to $89.87, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":114381,"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396411,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":true,"shares":82321,"price":59.94,"value":4934320.74,"ownership":{"direct":true},"balance_after":624231,"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396410,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":true,"shares":91121,"price":44.4,"value":4045772.4,"ownership":{"direct":true},"balance_after":541910,"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396409,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":true,"shares":213470,"price":38.4,"value":8197248.0,"ownership":{"direct":true},"balance_after":450789,"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396408,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":true,"shares":81709,"price":48.9,"value":3995570.1,"ownership":{"direct":true},"balance_after":237319,"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":396407,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2020-01-30T22:23:49.000Z","date":"2020-01-28","kind":"exercise","acquired":true,"shares":41229,"price":47,"value":1937763.0,"ownership":{"direct":true},"balance_after":155610,"source":{"system":"sec-edgar","filing":"0001179110-20-000889","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000889/edgar.xml","form_type":"4"}},{"id":401002,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2019-08-09T21:05:45.000Z","date":"2019-08-08","kind":"exercise","acquired":false,"shares":32363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":39.12,"exercise_date":"2017-02-21","expiration_date":"2024-02-20","underlying":"Common shares","underlying_shares":32363},"source":{"system":"sec-edgar","filing":"0001179110-19-009357","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019009357/edgar.xml","form_type":"4"}},{"id":401001,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2019-08-09T21:05:45.000Z","date":"2019-08-08","kind":"exercise","acquired":false,"shares":11400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":34.94,"exercise_date":"2016-02-15","expiration_date":"2023-02-14","underlying":"Common shares","underlying_shares":11400},"source":{"system":"sec-edgar","filing":"0001179110-19-009357","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019009357/edgar.xml","form_type":"4"}},{"id":401000,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2019-08-09T21:05:45.000Z","date":"2019-08-08","kind":"sale","acquired":false,"shares":43763,"price":85.7735,"value":3753705.6805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.50 to $86.21, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":114381,"source":{"system":"sec-edgar","filing":"0001179110-19-009357","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019009357/edgar.xml","form_type":"4"}},{"id":400999,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2019-08-09T21:05:45.000Z","date":"2019-08-08","kind":"exercise","acquired":true,"shares":32363,"price":39.12,"value":1266040.56,"ownership":{"direct":true},"balance_after":158144,"source":{"system":"sec-edgar","filing":"0001179110-19-009357","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019009357/edgar.xml","form_type":"4"}},{"id":400998,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2019-08-09T21:05:45.000Z","date":"2019-08-08","kind":"exercise","acquired":true,"shares":11400,"price":34.94,"value":398316.0,"ownership":{"direct":true},"balance_after":125781,"source":{"system":"sec-edgar","filing":"0001179110-19-009357","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019009357/edgar.xml","form_type":"4"}},{"id":406291,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2019-03-04T22:35:50.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":2246,"price":78,"value":175188.0,"ownership":{"direct":true},"balance_after":114381,"source":{"system":"sec-edgar","filing":"0001179110-19-003129","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019003129/edgar.xml","form_type":"4"}},{"id":406290,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2019-03-04T22:35:50.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":13127,"price":77.23,"value":1013798.21,"ownership":{"direct":true},"balance_after":116627,"source":{"system":"sec-edgar","filing":"0001179110-19-003129","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019003129/edgar.xml","form_type":"4"}},{"id":406851,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2019-02-26T22:15:16.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":169198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 56,399 on February 22, 2020, 56,399 on February 22, 2021, and 56,400 on February 22, 2022."}],"balance_after":169198,"derivative":{"exercise_price":75.9,"exercise_date":"2020-02-22","expiration_date":"2029-02-21","underlying":"Common shares","underlying_shares":169198},"source":{"system":"sec-edgar","filing":"0001179110-19-002651","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019002651/edgar.xml","form_type":"4"}},{"id":406850,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2019-02-26T22:15:16.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":32279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":129754,"source":{"system":"sec-edgar","filing":"0001179110-19-002651","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019002651/edgar.xml","form_type":"4"}},{"id":414319,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2018-06-05T21:04:06.000Z","date":"2018-06-01","kind":"tax_withholding","acquired":false,"shares":1713,"price":61.53,"value":105400.89,"ownership":{"direct":true},"balance_after":97475,"source":{"system":"sec-edgar","filing":"0001179110-18-008105","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018008105/edgar.xml","form_type":"4"}},{"id":417549,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2018-03-02T22:12:26.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":7379,"price":60.55,"value":446798.45,"ownership":{"direct":true},"balance_after":99188,"source":{"system":"sec-edgar","filing":"0001179110-18-003305","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003305/edgar.xml","form_type":"4"}},{"id":418565,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2018-02-21T23:19:07.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":246963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 82,321 on 02/16/2019, 82,321 on 02/16/2020, and 82,321 on 02/16/2021."}],"balance_after":246963,"derivative":{"exercise_price":59.94,"exercise_date":"2019-02-16","expiration_date":"2028-02-15","underlying":"Common shares","underlying_shares":246963},"source":{"system":"sec-edgar","filing":"0001179110-18-002509","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018002509/edgar.xml","form_type":"4"}},{"id":418564,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2018-02-21T23:19:07.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":44909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":106567,"source":{"system":"sec-edgar","filing":"0001179110-18-002509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018002509/edgar.xml","form_type":"4"}},{"id":425872,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2017-06-02T22:31:23.000Z","date":"2017-06-01","kind":"tax_withholding","acquired":false,"shares":1767,"price":45.66,"value":80681.22,"ownership":{"direct":true},"balance_after":61658,"source":{"system":"sec-edgar","filing":"0001179110-17-008471","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017008471/edgar.xml","form_type":"4"}},{"id":429009,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2017-03-02T22:19:05.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":1728,"price":45.39,"value":78433.92,"ownership":{"direct":true},"balance_after":63425,"source":{"system":"sec-edgar","filing":"0001179110-17-003683","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017003683/edgar.xml","form_type":"4"}},{"id":429008,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2017-03-02T22:19:05.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":4227,"price":45.46,"value":192159.42,"ownership":{"direct":true},"balance_after":65153,"source":{"system":"sec-edgar","filing":"0001179110-17-003683","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017003683/edgar.xml","form_type":"4"}},{"id":429716,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Option (right to buy)","published_at":"2017-02-22T23:08:34.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":136682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 45,561 on 2/17/2018, 45,560 on 2/17/2019, and 45,561 on 2/17/2020."}],"balance_after":136682,"derivative":{"exercise_price":44.4,"exercise_date":"2018-02-17","expiration_date":"2027-02-16","underlying":"Common shares","underlying_shares":136682},"source":{"system":"sec-edgar","filing":"0001179110-17-002965","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002965/edgar.xml","form_type":"4"}},{"id":429715,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common shares without par value","published_at":"2017-02-22T23:08:34.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":19763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":69380,"source":{"system":"sec-edgar","filing":"0001179110-17-002965","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002965/edgar.xml","form_type":"4"}},{"id":437647,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President and CFO"}}],"security":"Common shares without par value","published_at":"2016-06-03T21:10:01.000Z","date":"2016-06-01","kind":"sale","acquired":false,"shares":565,"price":39.491,"value":22312.415,"ownership":{"direct":true},"balance_after":49617,"source":{"system":"sec-edgar","filing":"0001179110-16-025994","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016025994/edgar.xml","form_type":"4"}},{"id":437646,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President and CFO"}}],"security":"Common shares without par value","published_at":"2016-06-03T21:10:01.000Z","date":"2016-06-01","kind":"tax_withholding","acquired":false,"shares":1203,"price":39.63,"value":47674.89,"ownership":{"direct":true},"balance_after":50182,"source":{"system":"sec-edgar","filing":"0001179110-16-025994","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016025994/edgar.xml","form_type":"4"}},{"id":441028,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President and CFO"}}],"security":"Common shares without par value","published_at":"2016-03-03T00:01:19.000Z","date":"2016-02-29","kind":"sale","acquired":false,"shares":700,"price":39.125,"value":27387.5,"ownership":{"direct":true},"balance_after":51385,"source":{"system":"sec-edgar","filing":"0001179110-16-020731","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016020731/edgar.xml","form_type":"4"}},{"id":441027,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President and CFO"}}],"security":"Common shares without par value","published_at":"2016-03-03T00:01:19.000Z","date":"2016-02-29","kind":"sale","acquired":false,"shares":165,"price":39.1223,"value":6455.1795,"ownership":{"direct":true},"balance_after":52085,"source":{"system":"sec-edgar","filing":"0001179110-16-020731","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016020731/edgar.xml","form_type":"4"}},{"id":441026,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President and CFO"}}],"security":"Common shares without par value","published_at":"2016-03-03T00:01:19.000Z","date":"2016-02-29","kind":"tax_withholding","acquired":false,"shares":1840,"price":39.52,"value":72716.8,"ownership":{"direct":true},"balance_after":52250,"source":{"system":"sec-edgar","filing":"0001179110-16-020731","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016020731/edgar.xml","form_type":"4"}},{"id":441606,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President and CFO"}}],"security":"Option (right to buy)","published_at":"2016-02-23T23:13:04.000Z","date":"2016-02-19","kind":"grant","acquired":true,"shares":213470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 71,157 on 02/19/2017, 71,156 on 02/19/2018, and 71,157 on 02/19/2019."}],"balance_after":213470,"derivative":{"exercise_price":38.4,"exercise_date":"2017-02-19","expiration_date":"2026-02-18","underlying":"Common shares","underlying_shares":213470},"source":{"system":"sec-edgar","filing":"0001179110-16-019929","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016019929/edgar.xml","form_type":"4"}},{"id":441605,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President and CFO"}}],"security":"Common shares without par value","published_at":"2016-02-23T23:13:04.000Z","date":"2016-02-19","kind":"grant","acquired":true,"shares":24348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":54090,"source":{"system":"sec-edgar","filing":"0001179110-16-019929","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016019929/edgar.xml","form_type":"4"}},{"id":450064,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President and CFO"}}],"security":"Option (right to buy)","published_at":"2015-06-03T21:38:06.000Z","date":"2015-06-01","kind":"grant","acquired":true,"shares":81709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,237 on 6/1/2016, 27,236 on 6/1/2017, and 27,236 on 6/1/2018."}],"balance_after":81709,"derivative":{"exercise_price":48.9,"exercise_date":"2016-06-01","expiration_date":"2025-05-31","underlying":"Common shares","underlying_shares":81709},"source":{"system":"sec-edgar","filing":"0001179110-15-009074","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015009074/edgar.xml","form_type":"4"}},{"id":450063,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15865,"kind":"person","name":"YOOR BRIAN B","position":1,"cik":"0001643528","reported_name":"YOOR BRIAN B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President and CFO"}}],"security":"Common shares without par value","published_at":"2015-06-03T21:38:06.000Z","date":"2015-06-01","kind":"grant","acquired":true,"shares":11596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":29742,"source":{"system":"sec-edgar","filing":"0001179110-15-009074","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015009074/edgar.xml","form_type":"4"}}]}